Encompass Health Corporation Equity Securities, FV-NI, Gain (Loss)
Encompass Health Corporation (EHC) reported Equity Securities, FV-NI, Gain (Loss) of $2.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-08-07
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was $2.40M, a 700.00% increase year-over-year.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-31 was -$200.00K, a 128.57% decline year-over-year.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for the quarter ending 2025-12-31 was $400.00K.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for the quarter ending 2025-09-30 was $1.10M, a 60.71% decline year-over-year.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for fiscal 2025 was $2.50M, a 150.00% increase from fiscal 2024.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for fiscal 2024 was $1.00M, a 42.86% increase from fiscal 2023.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for fiscal 2023 was $700.00K.
- Encompass Health Corporation equity securities, fv-ni, gain (loss) for fiscal 2022 was -$7.40M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.40M 10-Q · filed 2026-08-07 | $2.20M 10-Q · filed 2026-08-07 | $2.60M derived: sum of 3 quarters · filed 2026-08-07 | $3.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$200.00K 10-Q · filed 2026-05-01 | $200.00K derived: sum of 2 quarters · filed 2026-05-01 | $1.30M derived: sum of 3 quarters · filed 2026-05-01 | $1.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.50M derived: sum of 2 quarters · filed 2026-02-26 | $1.80M derived: sum of 3 quarters · filed 2026-08-07 | $2.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-10-31 | $1.40M derived: sum of 2 quarters · filed 2026-08-07 | $2.10M 10-Q · filed 2025-10-31 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-07 | $1.00M 10-Q · filed 2026-08-07 | -$700.00K derived: sum of 3 quarters · filed 2026-08-07 | $2.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-01 | -$1.00M derived: sum of 2 quarters · filed 2026-05-01 | $1.80M derived: sum of 3 quarters · filed 2026-05-01 | $1.40M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.10M derived: sum of 2 quarters · filed 2026-02-26 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.80M 10-Q · filed 2025-10-31 | $2.40M derived: sum of 2 quarters · filed 2025-10-31 | $2.70M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | -$400.00K 10-Q · filed 2025-08-06 | -$100.00K 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $700.00K 10-K · filed 2026-02-26 | |||
| 2022-12-31 | -$7.40M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |